feed,title,long_url,short_url
Investors,Sarepta Therapeutics Stock Falls On Delay In Quest For Muscular Dystrophy Treatment,https://www.investors.com/news/technology/srpt-stock-falls-after-fda-delays-muscular-dystrophy-drug-tests/,https://j.mp/3iiMqF0
